Sanctuary Advisors LLC purchased a new position in shares of Rentokil Initial plc (NYSE:RTO – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 29,334 shares of the company’s stock, valued at approximately $870,000.
Several other institutional investors also recently modified their holdings of RTO. CWM LLC lifted its holdings in Rentokil Initial by 7.4% during the 2nd quarter. CWM LLC now owns 5,551 shares of the company’s stock worth $165,000 after buying an additional 382 shares during the period. Truist Financial Corp boosted its holdings in Rentokil Initial by 2.6% in the second quarter. Truist Financial Corp now owns 16,008 shares of the company’s stock valued at $475,000 after acquiring an additional 401 shares during the last quarter. Signaturefd LLC boosted its holdings in Rentokil Initial by 3.4% in the second quarter. Signaturefd LLC now owns 12,321 shares of the company’s stock valued at $365,000 after acquiring an additional 406 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its position in Rentokil Initial by 81.3% during the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 968 shares of the company’s stock valued at $29,000 after purchasing an additional 434 shares during the period. Finally, SYSTM Wealth Solutions LLC raised its holdings in Rentokil Initial by 19.1% during the 2nd quarter. SYSTM Wealth Solutions LLC now owns 4,736 shares of the company’s stock worth $140,000 after purchasing an additional 759 shares during the last quarter. Institutional investors own 9.91% of the company’s stock.
Analysts Set New Price Targets
Several research firms have recently weighed in on RTO. Redburn Atlantic cut shares of Rentokil Initial from a “buy” rating to a “neutral” rating in a research report on Thursday, September 19th. UBS Group upgraded Rentokil Initial from a “sell” rating to a “neutral” rating in a report on Monday, July 1st. Sanford C. Bernstein raised Rentokil Initial from an “underperform” rating to a “market perform” rating in a research note on Monday, July 22nd. Finally, Barclays raised Rentokil Initial to a “strong-buy” rating in a research note on Friday, July 26th. Five research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $29.00.
Rentokil Initial Stock Down 0.4 %
NYSE:RTO opened at $23.37 on Friday. Rentokil Initial plc has a 12 month low of $23.33 and a 12 month high of $37.37. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04. The firm has a fifty day simple moving average of $28.25 and a two-hundred day simple moving average of $28.44.
Rentokil Initial Cuts Dividend
The company also recently announced a semi-annual dividend, which was paid on Tuesday, September 17th. Investors of record on Friday, August 9th were given a $0.2034 dividend. This represents a yield of 1.7%. The ex-dividend date was Friday, August 9th.
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
See Also
- Five stocks we like better than Rentokil Initial
- Where to Find Earnings Call Transcripts
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- The Most Important Warren Buffett Stock for Investors: His Own
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Using the MarketBeat Stock Split Calculator
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.